Dr Stephanie Burnell

2026

• Jackson, H. J. et al., 2026. Humoral immunity and variant cross-reactivity following asymptomatic and symptomatic Sars-Cov-2 infection and vaccination in young adults (the ACE cohort). Journal of Clinical Immunology (10.1007/s10875-026-02085-z)

2025

• Burnell, S. E. A. et al. 2025. OSCAR is an online ML-powered tool for organoid cell counting using bright-field images. Cell Reports: Methods 5 (12) 101251. (10.1016/j.crmeth.2025.101251)

2024

• Hopkins, G. et al., 2024. Lower humoral and cellular immunity following asymptomatic SARS-CoV-2 infection compared to symptomatic infection in education (the ACE cohort). Journal of Clinical Immunology 44 (6) 147. (10.1007/s10875-024-01739-0)

2022

• Pires, A. , Burnell, S. and Gallimore, A. 2022. Exploiting ECM remodelling to promote immune-mediated tumour destruction. Current Opinion in Immunology 74 , pp.32-38. (10.1016/j.coi.2021.09.006)
• Scurr, M. et al. 2022. Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid organ cancers. Immunology 165 (2), pp.250-259. (10.1111/imm.13433)

2021

• Burnell, S. E. A. et al. 2021. Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity. Immunotherapy Advances 2 (1) ltab025. (10.1093/immadv/ltab025)
• Teijeira Crespo, A. et al. 2021. Pouring petrol on the flames: using oncolytic virotherapies to enhance tumour immunogenicity. Immunology 163 (4), pp.389-398. (10.1111/imm.13323)
• Scourfield, D. O. et al. 2021. The role and uses of antibodies in COVID-19 infections: a living review. Oxford Open Immunology 2 (1) iqab003. (10.1093/oxfimm/iqab003)

2020

• Scurr, M. J. et al. 2020. Cancer antigen discovery is enabled by RNA-sequencing of highly purified malignant and non-malignant cells. Clinical Cancer Research (10.1158/1078-0432.CCR-19-3087)